# Decentralized Clinical Trials * **Definition:** A type of clinical trial that utilizes digital technology and decentralized methods to conduct research remotely, allowing for patient participation and data collection at locations convenient for participants, such as their homes, rather than requiring them to visit traditional clinical trial sites. * **Taxonomy:** Healthcare Topics / Decentralized Clinical Trials ## News * Selected news on the topic of **Decentralized Clinical Trials**, for healthcare technology leaders * 14K news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/14/2025 | [**Decentralized Clinical Trials Dcts Market Trend Analysis: Future Growth Opportunities and ...**](https://www.linkedin.com/pulse/decentralized-clinical-trials-dcts-market-trend-5mhpe) | [[Linkedin]] | | 5/7/2025 | [**AI and Decentralized Trials: A New Era in Drug Development - Healthcare IT Today**](https://www.healthcareittoday.com/2025/05/07/ai-and-decentralized-trials-a-new-era-in-drug-development/) | [[Healthcare IT Today]] | | 4/30/2025 | [**The Risk And Reward Of Clinical Investigators Integrating AI**](https://www.clinicalleader.com/doc/the-risk-and-reward-of-clinical-investigators-integrating-ai-0001) | [[Clinical Leader]] | | 4/22/2025 | [**The Growing Influence of Digital Health in Pharma - LinkedIn**](https://www.linkedin.com/pulse/growing-influence-digital-health-pharma-milan-sojitra-wgdwe) | [[Linkedin]] | | 2/25/2025 | [**Decentralized Clinical Trials (DCTs) Research Report 2025 - Yahoo Finance**](https://finance.yahoo.com/news/decentralized-clinical-trials-dcts-research-090200791.html) | [[Yahoo Finance]] | | 2/23/2025 | [**Global AI In Clinical Trials Market Trends Current Partnerships**](https://www.clinicalleader.com/doc/global-ai-in-clinical-trials-market-trends-current-partnerships-0001) | [[Clinical Leader]] | | 2/23/2025 | [**Global AI In Clinical Trials Market Trends Current Partnerships**](http://www.clinicalleader.com/doc/global-ai-in-clinical-trials-market-trends-current-partnerships-0001) | [[Clinical Leader]] | | 2/16/2025 | [**The Rise of Decentralized Clinical Trials: Transforming Medical Research in the Digital Age**](https://medium.com/@anand.butani/the-rise-of-decentralized-clinical-trials-transforming-medical-research-in-the-digital-age-14de2e771e75) | [[Medium]] | | 1/31/2025 | [**State-of-the-Art Innovations of Leading Startups in AI-Powered Clinical Trials - LinkedIn**](https://www.linkedin.com/pulse/state-of-the-art-innovations-leading-startups-trials-alex-g--ley1c) | [[Linkedin]] | | 1/29/2025 | [**Global Pharmaceutical R&D Outsourcing Market Research 2025 - Now Available - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20250129751453/en/Global-Pharmaceutical-RD-Outsourcing-Market-Research-2025-Now-Available---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 1/6/2025 | [**Clinical Trials Software Market Focused Insights 2024-2029: Dassault Systemes, BSI Business System Integration, Clario, IQVIA, Laboratory Corporation of America Holdings and Oracle Lead the Market - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20250106393997/en/Clinical-Trials-Software-Market-Focused-Insights-2024-2029-Dassault-Systemes-BSI-Business-System-Integration-Clario-IQVIA-Laboratory-Corporation-of-America-Holdings-and-Oracle-Lead-the-Market---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 1/6/2025 | [**Clinical Trials Software Market Focused Insights 2024-2029: Dassault Systemes, BSI Business System Integration, Clario, IQVIA, Laboratory Corporation of America Holdings and Oracle Lead the Market - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20250106393997/en/Clinical-Trials-Software-Market-Focused-Insights-2024-2029-Dassault-Systemes-BSI-Business-System-Integration-Clario-IQVIA-Laboratory-Corporation-of-America-Holdings-and-Oracle-Lead-the-Market---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/31/2024 | [**Funding Challenges for Innovation in MedTech in 2025 - HIT Consultant**](https://hitconsultant.net/2024/12/31/funding-challenges-for-innovation-in-medtech-in-2025/) | [[HIT Consultant]] | | 12/17/2024 | [**CRO Services Market Report 2024, with Key Player Profiles for Medpace, ICON, IQVIA ...**](https://finance.yahoo.com/news/cro-services-market-report-2024-193100039.html) | [[Yahoo Finance]] | | 12/7/2024 | [**Regional and Segment Trends in Decentralized Clinical Trials (DCTs) Market, Global ... - LinkedIn**](https://www.linkedin.com/pulse/regional-segment-trends-decentralized-clinical-trials-lyxgc) | [[Linkedin]] | | 12/1/2024 | [**Decentralized Clinical Trial Management - by MetforminSol - Nov, 2024 - Medium**](https://medium.com/@MetforminSol/decentralized-clinical-trial-management-c6fedb62f96c) | [[Medium]] | | 11/25/2024 | [**Digi-Tech Pharma & AI Conference 2025: AI and Genomics Take Center Stage (London ...**](https://www.marketwatch.com/press-release/digi-tech-pharma-ai-conference-2025-ai-and-genomics-take-center-stage-london-united-kingdom-may-28-29-2025-researchandmarkets-com-2a20b074) | [[MarketWatch]] | | 11/15/2024 | [**Virtual Clinical Trials Market Projected to Reach USD 14.89 Billion by 2032 with a CAGR of 6.07 SNS Insider**](https://finance.yahoo.com/news/virtual-clinical-trials-market-projected-140000642.html) | [[Yahoo Finance]] | | 11/13/2024 | [**CRO Summit Chair Muses On The Future Of CROs - Clinical Leader**](https://www.clinicalleader.com/doc/cro-summit-chair-muses-on-the-future-of-cros-0001) | [[Clinical Leader]] | | 11/13/2024 | [**AI in Healthcare Market to Grow by USD 20.34 Billion (2024-2028), Driven by ... - PR Newswire**](https://www.prnewswire.com/news-releases/ai-in-healthcare-market-to-grow-by-usd-20-34-billion-2024-2028-driven-by-healthcare-digitization-ai-powered-report-highlights-market-transformation---technavio-302304148.html) | [[PR Newswire]] | | 11/12/2024 | [**Innovations in Laboratory Testing for Decentralized Clinical Trials and Optimizations for ... - PRWeb**](https://www.prweb.com/releases/innovations-in-laboratory-testing-for-decentralized-clinical-trials-and-optimizations-for-future-upcoming-webinar-hosted-by-xtalks-302302623.html) | [[PRWeb]] | | 8/8/2024 | [**Novel AI model may enhance health data interoperability - Medical Xpress**](https://medicalxpress.com/news/2024-08-ai-health-interoperability.html) | [[MedicalXpress]] | | 8/6/2024 | [**FDA releases roster of digital health advisory committee, chaired by American College of Cardiology innovation officer**](https://www.fiercehealthcare.com/digital-health/fda-releases-roster-digital-health-advisory-committee-chaired-american-college) | [[FierceHealthcare]] | | 8/5/2024 | [**Digital Therapeutics Alliance CEO joins FDA Digital Health Advisory Committee and more ...**](https://www.mobihealthnews.com/news/digital-therapeutics-alliance-ceo-joins-fda-digital-health-advisory-committee-and-more-digital) | [[MobiHealthNews]] | | 7/9/2024 | [**Allucent Awarded 5-Year BARDA Agreement Aimed at Enhancing and Accelerating Decentralized Clinical Trials for Medical Countermeasure Development**](https://www.prnewswire.com/news-releases/allucent-awarded-5-year-barda-agreement-aimed-at-enhancing-and-accelerating-decentralized-clinical-trials-for-medical-countermeasure-development-302191338.html) | [[PR Newswire]] | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Science 37**: A pioneer in decentralized clinical trials, leveraging technology to conduct studies remotely and improve patient access. - **eClinical Solutions**: Recognized for its clinical data and analytics platforms, enhancing the efficiency of decentralized trials. - **GSK**: A global healthcare company transitioning towards decentralized clinical trials to enhance accessibility and improve health outcomes through technology integration. - **Walgreens**: A retail pharmacy chain expanding its clinical trials business and establishing partnerships to enhance decentralized clinical trials. - **Digital Therapeutics Alliance**: An organization represented by Andy Molnar, focusing on the regulation of digital health technologies including decentralized clinical trials. - **Medable**: A digital health platform that enables decentralized clinical trials by providing tools for remote patient engagement and data collection. - **Care Access**: A company focused on enhancing patient outreach and access to clinical trials, particularly in underserved communities. - **ICON Plc**: A leading global provider of outsourced development and commercialisation services to the pharmaceutical, biotechnology, and medical device industries, focusing on decentralized clinical trials. - **BARDA**: Biomedical Advanced Research and Development Authority, collaborating with Walgreens to improve decentralized clinical trials and public health research. - **Allucent**: A mid-sized clinical research organization selected by BARDA to enhance decentralized clinical study capabilities for medical countermeasures. - **Clinion**: A provider of eClinical solutions recognized for its contributions to clinical trial management and data integrity. - **Parexel**: A global biopharmaceutical services organization that supports decentralized trial methodologies to enhance patient recruitment and retention. - **myTomorrows**: Utilizes advanced technologies to improve patient access to clinical trials and treatment options, addressing recruitment and data collection challenges. - **Avandra**: The world's largest federated network for medical imaging and clinical data, facilitating clinical trial design and access to standardized datasets. - **IQVIA**: A leading provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, recognized for its decentralized clinical trial technology solutions. - **Signant Health**: A company offering integrated eClinical technology solutions to enhance clinical trial capabilities. - **Oracle Corporation**: A major player in clinical trials software, continuously innovating to maintain a competitive edge in the market. - **Thermo Fisher Scientific**: A leader in digital services for clinical development and patient engagement, recognized for its decentralized trial capabilities and advanced disease simulation technologies. - **Massive Bio**: An innovative company focused on improving clinical trial access for cancer patients globally, utilizing AI-driven platforms for trial matching. - **FDA**: The U.S. Food and Drug Administration, which is focusing on the regulation of digital health technologies and promoting diversity in clinical trials. ### Partnerships and Collaborations - **Allucent and BARDA**: Collaboration under the D-COHRe initiative to improve decentralized clinical trials for medical countermeasures. - **GSK and Medable**: Collaboration aimed at refining clinical trial strategies in the evolving landscape of decentralized research. - **Care Access and BARDA**: A multimillion-dollar agreement to leverage decentralized clinical trial networks for improving vaccine and treatment access. - **Delve Health and Withings Health Solutions**: Collaborating to integrate connected health devices for at-home monitoring in decentralized clinical trials. - **Sheba Medical Center and Paradigm Health**: Creating a global network to enhance clinical research and make trials more accessible. - **Trialbee and Belong.Life**: Collaborating to improve clinical trial recruitment by connecting qualified patients with research opportunities. - **Walgreens and BARDA**: A five-year partnership valued at up to $100 million aimed at enhancing decentralized clinical trials and improving access to clinical research. - **Atropos Health and QuantHealth**: Utilizing real-world data to optimize clinical trials through simulation of patient responses. - **EQBMED and Atrium Health**: Partnering to increase diversity in clinical trials and improve access through community-centered approaches. - **Signant Health and SPRIM PRO**: Strategic partnership to integrate eClinical technology solutions for enhanced clinical trial capabilities. - **Thermo Fisher Scientific and ISG**: Recognized for contributions to digital transformation in clinical trials, enhancing patient access and engagement. - **StoryCatch Partners and EmpiraMed**: Acquisition aimed at combining digital health capabilities with storytelling to improve participant engagement in virtual clinical studies. - **Avandra and Datavant**: Partnered to enhance the secure exchange of multimodal health data, integrating clinical and imaging data into Avandra's federated network. - **Intelligent Product Solutions and Digital Medicine Society**: Partnered in the HaH project to enhance at-home digitally-enabled healthcare. - **MetaPhy Health and ActiumHealth**: Collaborated to enhance patient engagement through AI-powered voice agents. - **Ellipsis Health and Ceras Health**: Partnership to enhance mental health care through AI-powered voice biomarker technology. - **BGB Group and TPG**: Partnered to accelerate growth through organic expansion and strategic partnerships, enhancing capabilities in medical communications and data analytics. - **Mass General Brigham and University of Wisconsin**: Collaborating with Microsoft to enhance AI use in medical imaging. ### Innovations, Trends, and Initiatives - **Decentralized Clinical Trials**: A growing trend in clinical research that utilizes digital health technologies to conduct trials remotely, improving patient access and engagement. - **Decentralized Clinical Trials (DCTs)**: Accelerated adoption due to COVID-19, allowing remote data collection and flexible trial designs, enhancing patient access and diversity. - **Decentralized Clinical Trials Market Growth**: Projected significant growth from 2022 to 2028, driven by technological advancements and a shift towards patient-centric research. - **FDA Guidance on DCTs**: The FDA has released guidance to promote decentralized clinical trials, emphasizing patient-centricity and technological innovation. - **D-COHRe Initiative**: Aimed at enhancing decentralized clinical study capabilities to improve public health emergency preparedness. - **Wearable Technology**: The use of wearables in decentralized clinical trials enables continuous health data collection, enhancing patient engagement and trial efficiency. - **Real-World Data (RWD)**: Emphasized in webinars to improve patient recruitment, diversity, and compliance in decentralized clinical trials. - **Global Clinical Trials Connect 2025**: A conference aimed at discussing advancements in clinical trials and research, focusing on innovative strategies and collaborations. - **Hybrid Trial Models**: Emerging as a solution to combine remote and site-based elements, improving patient engagement and reducing operational costs. - **Mobile Units**: Ark Clinical Research plans to launch mobile units to enhance accessibility and diversity in clinical trials for underserved communities. - **Augmented and Virtual Reality**: Technologies being introduced to enhance patient engagement and training in decentralized trials. - **Blockchain Technology**: Utilized in decentralized trials to ensure data integrity, security, and transparency, mitigating risks of data falsification. - **AI in Clinical Trials**: Increasingly utilized for site selection, patient identification, and retention, streamlining processes and reducing costs. - **eClinical Technologies**: Integration of electronic patient-reported outcomes (ePROs), electronic clinical outcome assessments (eCOAs), and telemedicine to streamline trial processes. - **TrialGPT**: An AI framework developed to assist healthcare providers in matching patients with relevant clinical trials, improving recruitment efficiency. - **Medable AI**: Generative AI technology that reduces the setup time for electronic Clinical Outcome Assessments (eCOAs) in decentralized trials. ### Challenges and Concerns - **Data Privacy and Security**: Concerns regarding the protection of patient data in decentralized clinical trials. - **Regulatory Compliance**: Challenges in ensuring compliance with evolving regulations in the context of decentralized clinical trials. - **Digital Infrastructure**: Insufficient digital infrastructure and high investment costs are barriers to the widespread adoption of decentralized clinical trials. - **Regulatory Hurdles**: Navigating regulatory frameworks for decentralized trials can be complex and requires ongoing collaboration with regulatory bodies. - **Management Complexity**: Decentralized trials introduce increased complexity in management and coordination of remote activities. - **Data Integrity**: Concerns regarding the accuracy and reliability of data collected in decentralized trials. - **Data Privacy**: Concerns regarding the security and privacy of patient data in decentralized trials and the use of AI technologies. - **Research Misconduct Risks**: Unique risks associated with decentralized trials that necessitate awareness and mitigation strategies. - **Integration with Legacy Systems**: Difficulties in integrating new technologies with existing healthcare systems may hinder the adoption of decentralized trials. - **Equitable Access to Technology**: Addressing disparities in access to technology is crucial for the success of decentralized trials. - **Participant Recruitment**: Despite advancements, many clinical trials still struggle to meet enrollment goals, necessitating innovative recruitment strategies. - **Data Quality and Privacy**: Challenges related to data quality and patient privacy in integrating real-world data and AI in clinical trials. - **Data Quality Concerns**: Ensuring the quality and reliability of data collected remotely remains a challenge. - **Funding for MedTech Startups**: Small and medium-sized organizations face significant funding challenges due to high development costs and complex regulatory pathways. ## Related Topics [[Clinical Trials]]; [[Diversity in Clinical Trials]]; [[Virtual Clinical Trials]]